Reginald Seeto - 28 Feb 2022 Form 4 Insider Report for CareDx, Inc. (CDNA)

Role
President and Chief Executive Officer, Director
Signature
/s/ Reginald Seeto
Issuer symbol
CDNA
Transactions as of
28 Feb 2022
Net transactions value
-$234,860
Form type
4
Filing time
01 Mar 2022, 19:49:36 UTC
Previous filing
10 Feb 2022
Next filing
23 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDNA Common Stock Award $0 +6,100 +3.2% $0.000000 196,270 28 Feb 2022 Direct F1
transaction CDNA Common Stock Tax liability $113,106 -2,947 -1.5% $38.38 193,323 28 Feb 2022 Direct F2
transaction CDNA Common Stock Sale $121,754 -3,153 -1.6% $38.62 190,170 01 Mar 2022 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities were represented by restricted performance stock units that were granted on November 2, 2020, 100% of which vested on February 28, 2022 upon the achievement of the requisite performance criteria.
F2 These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.
F3 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.30 to $39.07, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price.

Remarks:

President and Chief Executive Officer